Restoration of chemosensitivity in chemoresistant myeloma cells allows rechallenge of previously unsuccessful therapeutic agents, which might allow further disease control in patients with ...
Dauffenbach developed the Mosaic Blue assay for in vitro chemosensitivity testing of solid tumor explants, a method that is used to evaluate novel chemotherapeutic agents for activity prior to ...
Background: The pathogenesis of daytime hypercapnia (PaCO 2 ≥ 45 mm Hg) may be directly linked to the existence of obstructive sleep apnea syndrome (OSAS) per se, although only some patients ...
These findings highlight BRT's ability to enhance Gem chemosensitivity by inhibiting Nrf2 signaling in PDAC; therefore, BRT may serve as a potential adjuvant therapy for PDAC.